Veraxa Biotech AG
Ownership
Ownership Structure
Who owns Veraxa Biotech AG (VRXA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 2.7% of the shares are freely tradable; institutional investors hold 8.8%.
Largest Shareholders
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Nasdaq Composite Index | 0.06 | 86,011 | +0.0 | 07/31/2026 |
| Fidelity Nasdaq Composite ETF | 0.02 | 33,724 | +0.0 | 08/31/2026 |
| JNL Multi-Manager Alternative A | 0.01 | 7,745 | +0.0 | 06/30/2026 |
| JNL/Westchester Capital Event Driven A | 0.00 | 4,208 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Baumann Oliver Rolf | Director | 5,773,618 | 8,083,065 $ | Aug 27, 2026 | indirect |
| Antz Christoph Rudiger | Chief Executive Officer | 5,000 | 7,000 $ | Aug 27, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Baumann Oliver Rolf | Director | Buy | 50,000 | 1.50 | 75,000 |
| Aug 27, 2026 | Antz Christoph Rudiger | Chief Executive Officer | Buy | 5,000 | 1.53 | 7,650 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.